OraSure to Present at J.P Morgan Healthcare Conference
J.P. Morgan releases its annual look-ahead days before the entire biopharma industry descends on San Francisco for the annual ...
J.P. Morgan estimates that insured losses from the Los Angeles wildfires could approach $10 billion. The forecasted industry ...
J.P. Morgan Chase, with about 300,000 employees worldwide, is expected to announce the end of hybrid and remote work in the ...
J.P. Morgan Asset Management’s Michael Cembalest calls them “Alchemists” — the Trump White House nominees who are looking to ...
The company sought damages against Edward Turley, a former employee who was subject to more than a dozen customer complaints.
Josh Forstater has joined J.P. Morgan Asset Management as managing director, head of Everyday 401 (k), a retirement plan ...
GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer immunotherapies, today announced today announced its ...
J.P. Morgan analyst Doug Anmuth said he sees room for Alphabet, Google’s parent, to gain ground on a variety of fronts, ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference at ...
The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback